Dna X (SONM) Other Non-Current Liabilities (2018 - 2025)
Historic Other Non-Current Liabilities for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $1.8 million.
- Dna X's Other Non-Current Liabilities rose 1239.16% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 1239.16%. This contributed to the annual value of $1.7 million for FY2024, which is 1119.11% up from last year.
- According to the latest figures from Q3 2025, Dna X's Other Non-Current Liabilities is $1.8 million, which was up 1239.16% from $1.8 million recorded in Q2 2025.
- Over the past 5 years, Dna X's Other Non-Current Liabilities peaked at $1.8 million during Q3 2025, and registered a low of $1.3 million during Q1 2021.
- Over the past 5 years, Dna X's median Other Non-Current Liabilities value was $1.5 million (recorded in 2023), while the average stood at $1.5 million.
- As far as peak fluctuations go, Dna X's Other Non-Current Liabilities crashed by 4070.09% in 2021, and later soared by 1612.48% in 2025.
- Quarter analysis of 5 years shows Dna X's Other Non-Current Liabilities stood at $1.4 million in 2021, then increased by 1.42% to $1.4 million in 2022, then grew by 6.93% to $1.5 million in 2023, then increased by 11.19% to $1.7 million in 2024, then increased by 6.77% to $1.8 million in 2025.
- Its Other Non-Current Liabilities was $1.8 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.8 million in Q1 2025.